-
Je něco špatně v tomto záznamu ?
Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease
E. Mezeiova, K. Chalupova, E. Nepovimova, L. Gorecki, L. Prchal, D. Malinak, K. Kuca, O. Soukup, J. Korabecny,
Jazyk angličtina Země Spojené arabské emiráty
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- acetylcholinesterasa metabolismus MeSH
- Alzheimerova nemoc farmakoterapie metabolismus MeSH
- amyloidní beta-protein metabolismus MeSH
- cholinesterasové inhibitory farmakologie terapeutické užití MeSH
- donepezil analogy a deriváty MeSH
- lidé MeSH
- patologická konformace proteinů farmakoterapie metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Alzheimer's Disease (AD) is a neurodegenerative disorder with an increasing impact on society. Because currently available therapy has only a short-term effect, a huge number of novel compounds are developed every year exploiting knowledge of the various aspects of AD pathophysiology. To better address the pathological complexity of AD, one of the most extensively pursued strategies by medicinal chemists is based on Multi-target-directed Ligands (MTDLs). Donepezil is one of the currently approved drugs for AD therapy acting as an acetylcholinesterase inhibitor. In this review, we have made an extensive literature survey focusing on donepezil-derived MTDL hybrids primarily targeting on different levels cholinesterases and amyloid beta (Aβ) peptide. The targeting includes direct interaction of the compounds with Aβ, AChE-induced Aβ aggregation, inhibition of BACE-1 enzyme, and modulation of biometal balance thus impeding Aβ assembly.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025972
- 003
- CZ-PrNML
- 005
- 20221014094119.0
- 007
- ta
- 008
- 201125s2019 ts f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1567205016666190228122956 $2 doi
- 035 __
- $a (PubMed)30819078
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ts
- 100 1_
- $a Mezeiová, Eva $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. $7 xx0277560
- 245 10
- $a Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease / $c E. Mezeiova, K. Chalupova, E. Nepovimova, L. Gorecki, L. Prchal, D. Malinak, K. Kuca, O. Soukup, J. Korabecny,
- 520 9_
- $a Alzheimer's Disease (AD) is a neurodegenerative disorder with an increasing impact on society. Because currently available therapy has only a short-term effect, a huge number of novel compounds are developed every year exploiting knowledge of the various aspects of AD pathophysiology. To better address the pathological complexity of AD, one of the most extensively pursued strategies by medicinal chemists is based on Multi-target-directed Ligands (MTDLs). Donepezil is one of the currently approved drugs for AD therapy acting as an acetylcholinesterase inhibitor. In this review, we have made an extensive literature survey focusing on donepezil-derived MTDL hybrids primarily targeting on different levels cholinesterases and amyloid beta (Aβ) peptide. The targeting includes direct interaction of the compounds with Aβ, AChE-induced Aβ aggregation, inhibition of BACE-1 enzyme, and modulation of biometal balance thus impeding Aβ assembly.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a Alzheimerova nemoc $x farmakoterapie $x metabolismus $7 D000544
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cholinesterasové inhibitory $x farmakologie $x terapeutické užití $7 D002800
- 650 _2
- $a donepezil $x analogy a deriváty $7 D000077265
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a patologická konformace proteinů $x farmakoterapie $x metabolismus $7 D066263
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Chalupova, Katarina $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
- 700 1_
- $a Gorecki, Lukas $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 700 1_
- $a Prchal, Lukas $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
- 700 1_
- $a Malinak, David $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
- 700 1_
- $a Kuca, Kamil $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
- 700 1_
- $a Soukup, Ondrej $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 700 1_
- $a Korabecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00008816 $t Current Alzheimer research $x 1875-5828 $g Roč. 16, č. 9 (2019), s. 772-800
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30819078 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20221014094111 $b ABA008
- 999 __
- $a ok $b bmc $g 1600117 $s 1116658
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 16 $c 9 $d 772-800 $e - $i 1875-5828 $m Current Alzheimer research $n Curr Alzheimer Res $x MED00008816
- LZP __
- $a Pubmed-20201125